David Rikard Martinsson Holmdahl
Founder at Redoxis AB
Profile
Dr. David Rikard M.
Holmdahl, MD PhD, is a Professor at Karolinska Institutet, Chairman at Redoxis AB, and a Professor at University of Turku.
He is on the Board of Directors at ProNoxis AB.
Dr. Holmdahl was previously employed as a Professor by University of Lund.
David Rikard Martinsson Holmdahl active positions
| Companies | Position | Start |
|---|---|---|
Redoxis AB
 Redoxis AB Medical SpecialtiesHealth Technology Redoxis AB focuses on preclinical drug development and validation in autoimmune diseases. The firm focuses on preclinical development of small molecules that target molecular pathways in the immunological responses associated with autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. The company was founded by David Rikard Martinsson Holmdahl and Jan Peter Olofsson in 2007 and is headquartered in Gothenburg, Sweden. | Founder | 31/12/2006 |
| Karolinska Institutet | Corporate Officer/Principal | 21/12/2009 |
| University of Turku | Corporate Officer/Principal | 25/07/2011 |
Former positions of David Rikard Martinsson Holmdahl
| Companies | Position | End |
|---|---|---|
| University of Lund | Corporate Officer/Principal | 31/12/2006 |
ProNoxis AB
 ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Redoxis AB
Redoxis AB Medical SpecialtiesHealth Technology Redoxis AB focuses on preclinical drug development and validation in autoimmune diseases. The firm focuses on preclinical development of small molecules that target molecular pathways in the immunological responses associated with autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. The company was founded by David Rikard Martinsson Holmdahl and Jan Peter Olofsson in 2007 and is headquartered in Gothenburg, Sweden. | Health Technology |
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Health Technology |
- Stock Market
- Insiders
- David Rikard Martinsson Holmdahl
